Orlix®

Dosage form Application area Recommendations for use Contraindications Manufacturer
Read on
Certificate number:RU.77.99.88.003.Е.007871.07.15
Date of registration and renewal:20.07.2015
Dosage form: & nbspTablets weighing 0.3 g for sale to the population, "in bulk" packages of 5 kg and 500 blisters each - for subsequent packaging.
Classification "Composition" & nbsp Other dietary supplements
Classification "Clinical" & nbsp BAA, improving digestion and functional state of the digestive tract
Composition: & nbspComposition: E341, E460, E468, alpha-galactosidase, E470.
Scope: & nbspDFor the realization of the population as a biologically active food additive, the source of the digestive enzyme alpha-galactosidase, and also for subsequent packaging (in the "in bulk" package).
Suggested Usage: & nbspAT1 to 3 tablets with the first portions of food with the use of foods that cause flatulence.
Contraindications:ANDindividual intolerance of components, pregnancy, breast-feeding.
Special instructions: Before use, it is recommended to consult a doctor.
The product in the "in bulk" package is not subject to retail sale to the public, intended for subsequent packaging.
Shelf life:3 years.
Storage conditions:Store in a dry place inaccessible to children, at a temperature not exceeding 25 ° C.
Research protocols:EThe Federal Agency for Financial Monitoring of the Federal Frontier Guard and Federal Service for Consumer Rights Protection No. 10-2FTS / 2098 of May 28, 2015
Recipient:Valenta Farm, OJSCValenta Farm, OJSC Russian Federation
Information update date: & nbsp15.04.2016
Instructions
Up